E-Rehabilitation: Aerobic Resistance Training for Stroke Survivors
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02938000|
Recruitment Status : Completed
First Posted : October 19, 2016
Last Update Posted : August 22, 2018
|Condition or disease||Intervention/treatment||Phase|
|Stroke Hemiplegia||Device: Theraband with exercise video Other: usual care with advice to exercise||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||3 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||E-Rehabilitation: Aerobic Resistance Training for Stroke Survivors|
|Study Start Date :||August 2016|
|Actual Primary Completion Date :||March 2017|
|Actual Study Completion Date :||August 2017|
Experimental: Theraband group
This group will be furnished with Thera-band, and link to exercise video, with plans for regular exercise as described previously, in addition to usual post stroke care.
Device: Theraband with exercise video
Theraband exercise band for resistance training
Placebo Comparator: Usual Care Group
This group will have usual post stroke care, and will be advised to get regular exercise.
Other: usual care with advice to exercise
advice to exercise
- VO2: aerobic capacity measurement with peak VO2 using 6 minute walk test [ Time Frame: 12 weeks ]
- Berg Balance Score [ Time Frame: 12 weeks ]standardized questionnaire to assess balance difficulty following stroke.
- adherence to exercise program, interventional group only [ Time Frame: 12 weeks ]participants will be asked how many exercise sessions they have completed in the time frame.
- Patient Health Questionnaire - 9 (PHQ 9) [ Time Frame: 12 weeks ]standardized assessment for depression following stroke
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02938000
|United States, California|
|San Diego, California, United States, 92120|
|Principal Investigator:||William P Neil, MD||Kaiser Permanente|